0000950170-24-096419.txt : 20240813 0000950170-24-096419.hdr.sgml : 20240813 20240813170531 ACCESSION NUMBER: 0000950170-24-096419 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240809 FILED AS OF DATE: 20240813 DATE AS OF CHANGE: 20240813 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Glezer Eli N. CENTRAL INDEX KEY: 0001859694 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40443 FILM NUMBER: 241202780 MAIL ADDRESS: STREET 1: 10931 N. TORREY PINES ROAD, SUITE 100 CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Singular Genomics Systems, Inc. CENTRAL INDEX KEY: 0001850906 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 812948451 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3010 SCIENCE PARK ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 333-7830 MAIL ADDRESS: STREET 1: 3010 SCIENCE PARK ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 ownership.xml 4 X0508 4 2024-08-09 0001850906 Singular Genomics Systems, Inc. OMIC 0001859694 Glezer Eli N. 3010 SCIENCE PARK ROAD SAN DIEGO CA 92121 false true false false Chief Scientific Officer false Common Stock 2024-08-09 4 M false 500 A 154083 D Restricted Stock Units 2024-08-09 4 M false 500 D Common Stock 500 7000 D Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. On June 26, 2024, the Issuer effected a 1-for-30 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vest in 16 equal quarterly installments over four years measured from February 9, 2024. /s/ Dalen Meeter, Attorney-in-Fact 2024-08-13